Proposed H.R. 10336 Would Balance Innovation, Access to Dietary Supplements—Yet Change the Definition
On September 10, 2026, Congresswoman Diana Harshbarger (R-TN) introduced H.R. 10336—the Dietary Supplement Innovation Act—which would modernize the U.S. Food and Drug Administration’s (FDA) drug preclusion provision to encourage pharmaceutical innovation …